14391
document
Iloprost in cardiopulmonary bypass procedures . The inhibition of platelet aggregation during cardiopulmonary bypass and effects on post-operative placebo-controlled study of 145 patients . Significant preservation of platelet numbers and function were shown without significant haemodynamic problems , but no effect on cerebral deficits could be found . The use of iloprost in patients with severe thrombocytopenia seems justified , but the clinical benefits from its use in routine cardiopulmonary bypass remain to be shown .
14392
Intervention_Pharmacological
Iloprost
14393
Intervention_Control
placebo-controlled
14394
Intervention_Pharmacological
iloprost
14395
Participant_Condition
cardiopulmonary bypass
14396
Participant_Condition
placebo-controlled
14397
Participant_Sample-size
145
14398
Participant_Condition
severe thrombocytopenia